Results: 3

1.

Figure. From: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Fig 2 Estimated trend in the relative risk of cancer incidence by site or type per 10 unit increase in body mass index (BMI). Adjusted for age, geographical region, socioeconomic status, age at first birth, parity, smoking status, alcohol intake, physical activity, and, where appropriate, time since menopause and use of hormone replacement therapy. *Restricted to never users of hormone replacement therapy

Gillian K Reeves, et al. BMJ. 2007 December 1;335(7630):1134-1134.
2.

Figure. From: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Fig 1 Relative risk of cancer incidence and mortality for individual cancer sites or types according to body mass index (22.5-24.9=reference group). Adjusted for age, geographical region, socioeconomic status, age at first birth, parity, smoking status, alcohol intake, physical activity, and, where appropriate, time since menopause and use of hormone replacement therapy. Het=test for heterogeneity across categories of body mass index on df=4. *Restricted to never users of hormone replacement therapy

Gillian K Reeves, et al. BMJ. 2007 December 1;335(7630):1134-1134.
3.

Figure. From: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Fig 3 Estimated relative risk of incidence per 10 unit increase in body mass index (BMI) for cancer sites with at least 50 cases in premenopausal women, by menopausal status at entry in never users of hormone replacement therapy. Adjusted for age, geographical region, socioeconomic status, age at first birth, parity, smoking status, alcohol intake, and physical activity

Gillian K Reeves, et al. BMJ. 2007 December 1;335(7630):1134-1134.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk